Discovery of prognostic factors in Ewing's sarcoma family of tumors by use of Intercohort co-analysis of public gene expression datasets

被引：0
|
作者：
Bennani-Baiti, Idriss M.
Lawlor, Elizabeth R.
Cooper, Aaron
Kauer, Maximilian
Ban, Jozef
Aryee, Dave N. T.
Kovar, Heinrich
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3410
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Factors affecting survival outcomes of patients with non-metastatic Ewing’s sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center
    Wei Wan
    Yan Lou
    Zhiqi Hu
    Ting Wang
    Jinsong Li
    Yu Tang
    Zhipeng Wu
    Leqin Xu
    Xinghai Yang
    Dianwen Song
    Jianru Xiao
    Journal of Neuro-Oncology, 2017, 131 : 313 - 320
  • [42] Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center
    Wan, Wei
    Lou, Yan
    Hu, Zhiqi
    Wang, Ting
    Li, Jinsong
    Tang, Yu
    Wu, Zhipeng
    Xu, Leqin
    Yang, Xinghai
    Song, Dianwen
    Xiao, Jianru
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (02) : 313 - 320
  • [43] Combinatorial expression of histone modifying enzymes differentiates Ewing's sarcoma family of tumors from mesenchymal stem cells and other sarcomas
    Bennani-Baiti, Idriss M.
    Aryee, Dave
    Kovar, Heinrich
    CANCER RESEARCH, 2012, 72
  • [44] PROSPECTIVE VALIDATION ANCILLARY TO THE COOPERATIVE EURO-EWING99 TRIAL DOES NOT CONFIRM A PROGNOSTIC IMPACT FOR EWS-ETS FUSION TYPE IN EWING'S SARCOMA FAMILY TUMORS
    Kovar, Heinrich
    Le Deley, Marie-Cecile
    Delattre, Olivier
    Poremba, Christopher
    Schaefer, Karl-Ludwig
    Burchill, Sue A.
    Koehler, Gabriele
    Hogendoorn, Pancras C. W.
    Lion, Thomas
    Ballet, Stelly
    Pierron, Gaelle
    Brownhill, Samantha
    Nesslboeck, Michaela
    Marandet, Julien
    Ranft, Andreas
    Dirksen, Uta
    Juergens, Heribert
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 759 - 759
  • [45] Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli
    Bacci, G
    Ferrari, S
    Bertoni, F
    Rimondini, S
    Longhi, A
    Bacchini, P
    Forni, C
    Manfrini, M
    Donati, D
    Picci, P
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 4 - 11
  • [46] Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: A study by the United Kingdom cancer cytogenetics and the children's cancer and leukaemia group
    Roberts, Paul
    Burchill, Susan A.
    Brownhill, Samantha
    Cullinane, Catherine J.
    Johnston, Colin
    Griffiths, Mike J.
    McMullan, Dom J.
    Bown, Nick R.
    Morris, Stephen R.
    Lewis, Ian J.
    GENES CHROMOSOMES & CANCER, 2008, 47 (03): : 207 - 220
  • [47] HIF-1\#945; mediates hypoxia modulation of EWS-FLI1 expression in Ewing\#8217;s sarcoma family tumors
    Aryee, Dave
    Niedan, Stephan
    Muehlbacher, Karin
    Kauer, Max
    Ban, Jozef
    Bennani-Baiti, Idriss
    Kovar, Heinrich
    CANCER RESEARCH, 2009, 69
  • [48] Identifying prognosis and metastasis-associated genes associated with Ewing sarcoma by weighted gene co-expression network analysis
    Wang, Ben
    Li, Jie
    Li, Xin
    Ou, Yunsheng
    ONCOLOGY LETTERS, 2019, 18 (04) : 3527 - 3536
  • [49] Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family
    Choi, SH
    Kong, XT
    Taki, T
    Tsuchida, Y
    Kawaguchi, H
    Kato, H
    Hanada, R
    Look, AT
    Hayashi, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (04) : 463 - 467
  • [50] Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT)
    Machado, Isidro
    Antonio Lopez-Guerrero, Jose
    Scotlandi, Katia
    Picci, Piero
    Llombart-Bosch, Antonio
    VIRCHOWS ARCHIV, 2018, 472 (05) : 815 - 824
12345